person

Laurie S.

Country
The Netherlands
Department
Pulmonology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
6
Sites with multiple studies

Has run more than one trial at 6 of 108 partner sites.

Specializations

Lung Cancer Research

The investigator specializes in advancing therapeutic approaches for non-small cell lung cancer (NSCLC), with particular focus on developing innovative treatment combinations for patients with specific molecular alterations.

  • Advanced NSCLC Treatment Strategies
  • Targeted Therapy Combinations
  • Second and Third-line Therapies

Research interests include novel therapeutic approaches for metastatic NSCLC and treatment options following standard care progression.

Immunotherapy Applications

Primary research focus includes evaluating immunotherapy combinations and their efficacy in treating lung cancer, particularly investigating immune checkpoint inhibitor treatments.

  • PD-1/PD-L1 Inhibitor Therapy
  • Combination Immunotherapy Approaches
  • Treatment Response Assessment

The investigator explores therapeutic strategies involving immune checkpoint inhibitors in combination with other targeted agents.

Precision Medicine Development

Expertise in developing targeted therapeutic approaches for specific patient populations, with emphasis on molecular-based treatment selection.

  • Molecular-Guided Therapy
  • Treatment Optimization
  • Drug Combination Studies

Research encompasses determining optimal dosing and combinations of novel therapeutic agents for personalized treatment strategies.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.